Results 51 to 60 of about 3,965 (158)
Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin Effect on platelet function and thrombus formation [PDF]
, 2004 ObjectivesThe goal of this study was to compare the antithrombotic effects of enoxaparin versus unfractionated heparin (UFH) when combined with eptifibatide in acute coronary syndrome (ACS) patients.BackgroundAn increasing number of high-risk ACS ...
Tobar, Ana +8 more
core +1 more source
, 2013 A. Eptifibatide treated mice had lower sepsis scores than vehicle treated mice at time points following drug administration. For example, at the 20 hour injection, the mean±SEM vehicle treated score was 8.4±0.3 while the eptifibatide treated score was 7 ...
Angela S. Benton (314055) +7 more
core +1 more source
Eptifibatide-induced profound thrombocytopaenia: a rare complication.
, 2021 Drug-induced immune thrombocytopaenia (DITP) is a type of thrombocytopaenia caused by medications. It is one of the common causes of unexplained thrombocytopaenia.
Azimi, Roxana +3 more
core +1 more source
Eptifibatide-induced thrombocytopenia leading to acute stent thrombosis
, 2016 A 71-year old female patient with inferior ST- elevation myocardial infarction underwent primary percu- taneous coronary intervention (PCI) within 3 h of symptom onset. She was preloaded with 300 mg aspirin and 600 mg clopidogrel before PCI.
Faluközy, József +6 more
core +1 more source
Cardiovascular Diabetology, 2008 Background The use of abciximab (c7E3 Fab) or eptifibatide improves clinical outcomes in diabetics undergoing percutaneous coronary intervention. These β3 integrin inhibitors antagonize fibrinogen binding to αIIbβ3 integrins on platelets and ligand ...
Huang Jianhua +3 more
doaj +1 more source
Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia. [PDF]
, 2011 A 57-year-old man with a history of coronary artery disease and placement of an implantable cardioverter-defibrillator presented at our emergency room with an anterior ST-elevation myocardial infarction.
Yang, Eric H +3 more
core +1 more source
, 2011 Objective: To report the use of extended-infusion eptifibatide in a patient who had undergone placement of a drug-eluting stent and required repeat intervention of a hip fracture following mechanical failure.
Matthew J Kauflin, Bryan D Lizza
core +1 more source
Кардиоваскулярная терапия и профилактика, 2008 The review presents literature data on the key role of platelet aggregation (PA) for intracoronary thrombogenesis in various acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI).
T. A. Batyraliev +4 more
doaj
Modulação das respostas de activação plaquetária pelo eptifibatide: uma abordagem citómica e proteómica [PDF]
, 2011 Os antiplaquetários são actualmente bastante utilizados no controlo das doenças cardiovasculares, a principal causa de morte no mundo ocidental.
Andrade, Cláudia Sofia Coutinho
core +1 more source
, 2004 Purpose To provide outcome data to health care practitioners involved in the care of patients undergoing percutaneous coronary intervention (PCI). Adjunctive treatment with eptifibatide can be used in a wide range of patients requiring glycoprotein IIb ...
Joseph G. Ottinger
core +2 more sources